966P Diabetes therapy burden as proxy of impairment of immune checkpoint inhibitors efficacy

Autor:	Riccardo Marconcini, A. Russo, M. De Tursi, Paola Queirolo, Daniele Santini, Alessio Cortellini, Marco Tucci, G. Porzio, Alain Gelibter, Francesco Grossi, S. Cleary, David J. Pinato, P.A. Ascierto, Domenico Mallardo, Federica Zoratto, Enrica Teresa Tanda, Francesca Rastelli, Marco Filetti, Rita Chiari, Melissa Bersanelli
Jazyk:	angličtina
Rok vydání:	2021
Předmět:	Oncology medicine.medical_specialty business.industry Internal medicine Immune checkpoint inhibitors medicine Hematology Proxy (statistics) business Diabetes Therapy
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3f4a2bbf3e28fd0565df49757404bab https://hdl.handle.net/11573/1667541 Zobrazit plný text záznamu